Nolicin (Norfloxacin)

Norfloxacin blocks two essential bacterial enzymes—DNA gyrase and topoisomerase IV—preventing DNA replication and transcription. This inhibition stops bacterial cells from multiplying, ultimately leading to bacterial death and resolution of the infection.

The dosage of Nolicin is determined by the prescribing healthcare professional based on the type and severity of the infection, patient age, kidney function, and other clinical factors. Patients should follow the prescriber’s instructions and not alter the dose on their own.

The safety of Norfloxacin in pregnancy and lactation has not been definitively established. It is generally avoided unless the potential benefit outweighs the risk, and the decision should be made by a qualified healthcare provider after evaluating the individual situation.

To request Nolicin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noricloxacin shares the same class mechanism as other fluoroquinolones but differs in its spectrum of activity, pharmacokinetic profile, and tissue penetration. Clinicians may select Noricloxacin over alternatives based on susceptibility patterns, infection site, and patient‑specific factors such as renal function.

Nolicin tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Do not store in humid environments or expose the tablets to excessive heat.

Nolicin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminium or magnesium as they may reduce absorption.

Serious adverse events, although rare, include tendon rupture (especially the Achilles tendon), QT‑interval prolongation that can lead to cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, or signs of a severe allergy.

Nolicin should be avoided in individuals with a known hypersensitivity to Norfloxacin or any fluoroquinolone, in patients with a history of tendon disorders related to fluoroquinolone use, and in those with significant QT‑prolongation unless benefits outweigh the risks.